Product Information
SEVELAMER 2.4 GM POWDER PACKET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $1.0050 per EA under NDC 33342028968. Its NADAC has been published 83 times since Mar 5, 2025.
FDA first approved this application on Apr 25, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.4 g/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342028968
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SEVELAMER CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA207291FDA Approved
4/25/2024
TE Code
AB
On Market Since
4/26/2024
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER 2.4 GM POWDER PACKET has been published 83 times since Mar 5, 2025, and over the history we have for it it has declined 32.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0050 per EA |
|---|---|
| All-time high | $1.5517 (Aug 13, 2025) |
| All-time low | $0.9356 (Jan 21, 2026) |
| 52-week high | $1.3623 |
| 52-week low | $0.9356 |
| Median price | $1.1337 |
| Average price | $1.2228 |
| Largest weekly change | -11.6% (Nov 19, 2025) |
| Weeks tracked | 83 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SEVELAMER CARBONATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SEVELAMER CARBONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SEVELAMER 2.4 GM POWDER PACKET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER 2.4 GM POWDER PACKET, manufactured by Macleods Pharmaceuticals Limited, is $1.0050 per EA (NDC 33342028968), effective Sep 30, 2026.
How has the price of SEVELAMER 2.4 GM POWDER PACKET changed over time?
Over the history we have for it, the NADAC for SEVELAMER 2.4 GM POWDER PACKET has declined 32.7%. It has been tracked across 83 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for SEVELAMER 2.4 GM POWDER PACKET?
Since Mar 5, 2025, the NADAC for SEVELAMER 2.4 GM POWDER PACKET has ranged from a low of $0.9356 (Jan 21, 2026) to a high of $1.5517 (Aug 13, 2025), with a median of $1.1337 per EA.
Are there cheaper alternatives to SEVELAMER 2.4 GM POWDER PACKET?
No other NADAC-published product currently shares the active ingredient and strength of SEVELAMER 2.4 GM POWDER PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SEVELAMER 2.4 GM POWDER PACKET?
SEVELAMER 2.4 GM POWDER PACKET (NDC 33342028968) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.